ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) COO Muthusamy Shanmugam sold 6,242 shares of ANI Pharmaceuticals stock in a transaction dated Wednesday, October 18th. The shares were sold at an average price of $57.78, for a total transaction of $360,662.76. Following the transaction, the chief operating officer now owns 1,042,620 shares of the company’s […]
Mach 1 Financial Group LLC acquired a new position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 9,330 shares of the specialty pharmaceutical company’s stock, valued at approximately $502,000. Mach 1 Financial Group LLC […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $3.62-$4.11 for the period, compared to the consensus estimate of $3.97. The company issued revenue guidance of $425.00 million-$445.00 million, compared to the consensus revenue estimate of $442.97 million. Analysts Set […]
BTC Capital Management Inc. grew its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 10.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,337 shares of the specialty pharmaceutical company’s stock after purchasing an additional 693 shares during the […]